As of 2025-02-19, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (63.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.12 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -799.3%.
The range of the Relative Valuation is (65.25) - (72.39) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 19.4x - 38.2x | 28.8x |
Forward P/E multiples | 32.0x - 35.5x | 33.8x |
Fair Price | (65.25) - (72.39) | (63.77) |
Upside | -815.5% - -893.7% | -799.3% |
Date | P/E |